BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shobab L, Burman KD, Wartofsky L. Sex Differences in Differentiated Thyroid Cancer. Thyroid 2021. [PMID: 34969307 DOI: 10.1089/thy.2021.0361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi W, Wu W, Zhang L, Jia Q, Tan J, Zheng W, Li N, Xu K, Meng Z. Prognosis of thyroid carcinoma patients with osseous metastases: an SEER-based study with machine learning. Ann Nucl Med 2023. [PMID: 36867400 DOI: 10.1007/s12149-023-01826-z] [Reference Citation Analysis]
2 Köhrle J. Selenium, Iodine and Iron-Essential Trace Elements for Thyroid Hormone Synthesis and Metabolism. Int J Mol Sci 2023;24. [PMID: 36834802 DOI: 10.3390/ijms24043393] [Reference Citation Analysis]
3 Min Y, Liu Z, Huang R, Li R, Jin J, Wei Z, He L, Pei Y, Li N, Su Y, Hu X, Peng X. Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study. J Transl Med 2022;20:560. [PMID: 36463201 DOI: 10.1186/s12967-022-03719-7] [Reference Citation Analysis]
4 Zhang L, Zhang J, Fan S, Zhong Y, Li J, Zhao Y, Ni S, Liu J, Wu Y. A case-control study of urinary concentrations of bisphenol A, bisphenol F, and bisphenol S and the risk of papillary thyroid cancer. Chemosphere 2022. [DOI: 10.1016/j.chemosphere.2022.137162] [Reference Citation Analysis]
5 Wilmouth JJ Jr, Olabe J, Garcia-Garcia D, Lucas C, Guiton R, Roucher-Boulez F, Dufour D, Damon-Soubeyrand C, Sahut-Barnola I, Pointud JC, Renaud Y, Levasseur A, Tauveron I, Lefrançois-Martinez AM, Martinez A, Val P. Sexually dimorphic activation of innate antitumor immunity prevents adrenocortical carcinoma development. Sci Adv 2022;8:eadd0422. [PMID: 36240276 DOI: 10.1126/sciadv.add0422] [Reference Citation Analysis]
6 Lee EK, Moon JH, Hwangbo Y, Ryu CH, Cho SW, Choi JY, Chung EJ, Jeong W, Jung Y, Ryu J, Kim S, Kim MJ, Kim YK, Lee CY, Lee JY, Yu HW, Hah JH, Lee KE, Lee YJ, Park SK, Park DJ, Kim J, Park YJ. Progression of Low-risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) in Korea. Thyroid 2022. [DOI: 10.1089/thy.2021.0614] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Ghali MS, El Ansari W, Abdelaal A, Al Hassan MS. Behaviour and epidemiology of differentiated thyroid cancer among filipinos in and outside the Philippines: Comparison between Qatar, Canada and Philippines. Annals of Medicine and Surgery 2022;81:104202. [DOI: 10.1016/j.amsu.2022.104202] [Reference Citation Analysis]
8 Lam D, Davies L, Sawka AM. Women and thyroid cancer incidence: overdiagnosis versus biological risk. Curr Opin Endocrinol Diabetes Obes 2022. [PMID: 35855551 DOI: 10.1097/MED.0000000000000756] [Reference Citation Analysis]
9 Kim H, Kwon H, Moon BI. Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter? Cancers (Basel) 2022;14. [PMID: 35454803 DOI: 10.3390/cancers14081896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]